HomeAI · summaries
Storia in 2 fonti
Biotech IPO gains crush AI listings with standout 55% return
Drivers of biotech and pharma’s outperformance include a 13 per cent gain in the Nasdaq Biotechnology index this year. Find out more here.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
financialpost.com
Biotech IPO gains crush AI listings with standout 55% return
Drivers of biotech and pharma’s outperformance include a 13 per cent gain in the Nasdaq Biotechnology index this year. Find out more here.
- ·
cryptobriefing.com
Biotech IPOs lead 2026 US market, overshadowing AI firms like Anthropic
Biotech IPOs dominate the 2026 US market, overshadowing AI firms like Anthropic. Anthropic's IPO by December 31, 2026 at 63.5% YES.